Share 'Pharmaceutical mergers: what WOULD you do?'

Last week, the impending merger of Pfizer and Wyeth sparked some very interesting dialogue, with voices for and against the fusion of a new pharmaceutical giant. There was a quite a bit of negative opinion against further M&A activity in the sector. It seems that less time is spent on the positive side - what strategic decisions would you see as valuable? After all, if CI is looking to incre…